Article Text

Download PDFPDF

MMP12 and reduced risk of COPD
  1. A Pillai
  1. North Bristol Lung Centre, Bristol
  1. Correspondence to Anilkumar Pillai, Gloucestershire Royal Hospital, UK; anilkumarpillai{at}

Statistics from

Not all smokers develop chronic obstructive pulmonary disease (COPD), and not everyone with COPD has the same rate of decline of lung function. In this study the authors hypothesised that matrix metalloproteinase 12 (MMP12) variants have a role in lung function and are risk factors for COPD. MMP12 is produced by …

View Full Text

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.